Memory T cell populations, including central memory T cells and effector memory T cells, were markedly elevated in the PGFP+, PGF+, and PTPR treatment groups (Figure 7I,J; Figure S11, Supporting Information), suggesting that the PGFP+ strategy promotes immune memory formation—essential for sustaining the anti‐tumor effects and preventing metastasis. Here, PTPRR is linked to neoplasm.